{"SPADE_UN_23164": {"Sequence Information": {"Peptide Name": "", "Sequence": "XXLFXXLLXYLXXF", "Sequence Length": 14, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "D- and Unnatural Amino Acid Substituted Antimicrobial Peptides With Improved Proteolytic Resistance and Their Proteolytic Degradation Characteristics.", "Pubmed ID": "33281761", "Reference": "Front Microbiol. 2020;11:563030", "Author": "Lu J, Xu H, Xia J, Ma J, Xu J, Li Y, Feng J", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/33281761"}], "SPADE ID": "SPADE_UN_23164", "Similar Sequences": [{"SPADE_ID": "SPADE_N_05122", "Similarity": 1.0, "Sequence": "MANLLISEKSYYEKLVEAETANEFRMVLIRLINRVVMKVKVPLEVRELFL"}, {"SPADE_ID": "SPADE_N_11007", "Similarity": 1.0, "Sequence": "LFL"}, {"SPADE_ID": "SPADE_N_11033", "Similarity": 1.0, "Sequence": "ALFL"}], "Hemolytic Activity": "Human erythrocytes:17.41±1.82% Hemolysis=32 µM,Human erythrocytes:41.03±1.38% Hemolysis=64 µM,Human erythrocytes:100% Hemolysis=128 µM", "Target Organism": "Escherichia coli ATCC 25922(MIC=2µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=2µg/ml),Pseudomonas aeruginosa(MIC=4µg/ml),Acinetobacter baumannii ATCC 19606(MIC=2µg/ml),Acinetobacter baumannii(MIC=2µg/ml),Staphylococcus aureus ATCC 25923(MIC=0.5µg/ml),Candida albicans ATCC 10231(MIC=4µg/ml),Murine macrophage cells RAW 264.7(IC50=21.74±4.14µM)"}}}